- NOK14.72bn
- NOK25.88bn
- $795.00m
- 40
- 67
- 53
- 53
C2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 333 | 566 | 565 | 967 | 795 |
Cost of Revenue | |||||
Gross Profit | 162 | 271 | 272 | 644 | 455 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 584 | 509 | 428 | 489 | 476 |
Operating Profit | -251 | 57 | 137 | 478 | 319 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -199 | -18 | 5 | 309 | 244 |
Provision for Income Taxes | |||||
Net Income After Taxes | 215 | 17 | -53 | -8.8 | 110 |
Net Income Before Extraordinary Items | |||||
Net Income | 215 | 17 | -53 | -8.8 | 110 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 214 | 17 | -53 | -8.8 | 110 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 64.6 | 0.595 | -1.98 | 0.046 | 4.38 |
Dividends per Share |